For research use only. Not for therapeutic Use.
PROTAC BET-binding moiety 2 is an inhibitor of BET bromodomain[1].
| Catalog Number | I019321 |
| CAS Number | 916493-82-8 |
| Synonyms | (9S)-7-(4-chlorophenyl)-9-(2-methoxy-2-oxoethyl)-5,13-dimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene-4-carboxylic acid |
| Molecular Formula | C20H17ClN4O4S |
| Purity | ≥95% |
| InChI | InChI=1S/C20H17ClN4O4S/c1-9-15-16(11-4-6-12(21)7-5-11)22-13(8-14(26)29-3)18-24-23-10(2)25(18)19(15)30-17(9)20(27)28/h4-7,13H,8H2,1-3H3,(H,27,28)/t13-/m0/s1 |
| InChIKey | LZXZWZXAVDJSIL-ZDUSSCGKSA-N |
| SMILES | CC1=C(SC2=C1C(=NC(C3=NN=C(N32)C)CC(=O)OC)C4=CC=C(C=C4)Cl)C(=O)O |
| Reference | [1]. James E. Bradner, et al. Bivalent bromodomain inhibtors and uses thereof. WO2017091673A2. |
